Literature DB >> 1105647

Studies on the nature and causes of hyperlipidaemia in uraemia, maintenance dialysis and renal transplantation.

L S Ibels, L A Simons, J O King, P F Williams, F C Neale, J H Stewart.   

Abstract

Fasting serum triglyceride and cholesterol measurements, and lipoprotein characterization by ultracentrifugation, were performed in four groups of patients with chronic renal disease (uraemic, short- and long-term haemodialysis and renal transplant recipients) and the results compared with those obtained from age- and sex-matched control subjects. Basal insulin and growth hormone levels, and serum creatinine and albumin concentrations were measured in, and detailed dietary histories taken from patients in each group. The predominant lipid abnormalities were hypertriglyceridaemia and increased very low density lipoproteins (type IV hyperlipoproteinaemia) in both uraemic and haemodialysis patients. Following renal transplantation, a different pattern of hyperlipidaemia was found. Hypercholesterolaemia was more common and hypertriglyceridaemia less common than in the uraemic and haemodialysis group. The lipoprotein abnormalities were increased low density and/or very low density lipoproteins, with types IIa IIb and IV hyperlipoproteinaemia occurring equally frequently. In uraemic and haemodialysis patients, the proportion of carbohydrate in the diet was high, and may have played a role in the genesis of hypertriglyceridaemia. There was a positive correlation between relative body weight and serum triglyceride in the long-term dialysis group. In renal allograft recipients hypertriglyceridaemia could be attributed, at least in part, to obesity, prednisone dosage and the degree of impairment of graft function. The aetiology of hypercholesterolaemia in the transplant recipients was unclear. Neither basal insulin nor growth hormone levels were elevated in any patient group. Uraemic hypertriglyceridaemia is a clearly defined and well documented metabolic abnormality which is not corrected by dialysis. Post-transplantation hyperlipidaemia however, is a condition of variable presentation and multifactorial aetiology.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1105647

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  11 in total

1.  High-density lipoprotein in chronic renal failure and after renal transplantation.

Authors:  E Savdie; J C Gibson; J H Stewart; L A Simons
Journal:  Br Med J       Date:  1979-04-07

2.  A morphometric study of arterial intimal thickening in kidneys of dialyzed patients.

Authors:  T Nishi; C Bond; G Brown; K Solez; R H Heptinstall
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

Review 3.  Morbidity and mortality of long-term haemodialysis: a review.

Authors:  R Gabriel
Journal:  J R Soc Med       Date:  1984-07       Impact factor: 5.344

4.  The effect of growth hormone on the growth failure of chronic renal failure.

Authors:  F Santos; J C Chan; J D Hanna; K Niimi; R J Krieg; M D Wellons
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

Review 5.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

Review 6.  Management of hyperlipidaemia associated with heart transplantation.

Authors:  Klaus Wenke
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.

Authors:  Johannes M M Boots; Maarten H L Christiaans; Johannes P van Hooff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Hyperlipidaemia in children on regular haemodialysis.

Authors:  M El-Bishti; R Counahan; R J Jarrett; L Stimmler; V Wass; C Chantler
Journal:  Arch Dis Child       Date:  1977-12       Impact factor: 3.791

Review 9.  Disturbances of lipid metabolism in children with chronic renal failure.

Authors:  U Querfeld
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

Review 10.  Endocrine and metabolic abnormalities following kidney transplantation.

Authors:  W H Hörl; W Riegel; C Wanner; M Haag-Weber; P Schollmeyer; H Wieland; H Wilms
Journal:  Klin Wochenschr       Date:  1989-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.